Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

要点速览

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

背景说明

本条为自动化整理的行业快讯，未经本站独立核实。产品功能、价格与开放范围可能随时变化，请以官方发布为准。